Insulin glargine with step-wise addition of insulin glulisine or with one injection of insulin glulisine vs a twice-daily premixed insulin regimen (insulin aspart mix 70/30) in adult subjects with type-2 diabetes failing dual or triple therapy with oral agents.
Phase of Trial: Phase IV
Latest Information Update: 16 Sep 2011
At a glance
- Drugs Insulin aspart/insulin protamine aspart; Insulin glargine; Insulin glulisine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Sanofi
- 31 Aug 2018 Biomarkers information updated
- 16 Sep 2011 Results presented at the 47th Annual Meeting of the European Association for the Study of Diabetes.
- 12 Sep 2011 Results presented at the 47th Annual Meeting of the European Association for the Study of Diabetes (EASD-2011).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History